On its third quarter of 2026 earnings call, held on Oct. 21, 2026, Abbott (ABT -1.89%) announced its plan to spin off its nutrition business into an independent public company. Shedding consumer nutrition sharpens focus on higher-margin medical technologies and diagnostics. The move leaves behind an enterprise with faster underlying sales expansion. Three takeaways from the call stand out. 3. Pulsed Field Ablation Powers Electrophysiology Expansion New catheter technology and expanding regulatory approvals ...

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026 SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026 Sera Prognostics, Inc. Oct 21, 2026, 16:05 ET SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker informatio ...

Abbott Laboratories reports third-quarter 2026 results before the market opens on October 21, 2026. Abbott Laboratories sells medical devices, diagnostic tests, nutrition products, and medicines. Adjusted earnings are $1.42 per share, matching estimates. Revenue is $13.01 billion, slightly above the $12.99 billion estimate. Abbott reports sales growth of 14.5% and comparable sales growth of 7.0%. Comparable sales growth includes Exact Sciences, which Abbott acquired on March 23, 2026. Under standard account ...

CEO Julie Sawyer Montgomery credits stronger demand and the Danaher Business System, the company's approach to improving operations, for double-digit growth in adjusted earnings per share. Adjusted earnings leave out certain items to help show ongoing performance. The company says its results and comparisons cover continuing operations and are year over year unless noted otherwise. Danaher has a trailing price-to-earnings ratio of 36.6, meaning its share price is 36.6 times earnings from the past 12 months. ...

Key Takeaways Danaher's Q3 adjusted EPS rose 11.6% to $2.11, beating estimates by 9.9%.Diagnostics sales jumped 17%, driven by acquisitions, while core sales excluding respiratory testing rose 7%.Danaher raised 2026 adjusted EPS guidance to $8.57-$8.62, targeting 2.5% core revenue growth.Danaher Corporation (DHR) reported third-quarter 2026 adjusted earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.92 by 9.9%. The bottom line increased 11.6% year over year from $1.89 per share. Stronge ...

Key Takeaways Abbott's Q3 adjusted EPS missed estimates by 0.7%, while sales rose 14.5% to $13.01 billion.Abbott's Medical Devices and Diagnostics posted growth, while Nutrition sales rose 4.9% on a comparable basis.Abbott expanded gross and operating margins but lowered its 2026 comparable sales growth outlook to 6%.Abbott (ABT) reported third-quarter 2026 adjusted earnings per share of $1.42, up 9.2% year over year. The figure missed the Zacks Consensus Estimate by 0.7%.Sales increased 14.5% year over yea ...

Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings call October 21, 2026 09:00 AM ET Speaker0Good morning, and thank you for standing by. Welcome to Abbott's third quarter 2026 earnings conference call. All participants will be able to listen only until the question and answer portion of this call. During the question and answer session, you will be able to ask your question by pressing the star 11 keys on your touchtone phone. This call is being recorded by Abbott. With the exception of any participant's ques ...

Danaher (NYSE:DHR) Q3 2026 Earnings call October 21, 2026 08:00 AM ET Company ParticipantsRachel Vatnsdal - VP of Investor RelationsJulie Sawyer Montgomery - President and CEOMatt Gugino - EVP and CFOConference Call ParticipantsDoug Schenkel - AnalystVijay Kumar - AnalystTycho Peterson - AnalystJack Meehan - AnalystScott Davis - AnalystCasey Woodring - AnalystEvie Koslosky - AnalystOperatorMy name is Chelsea, and I will be your conference facilitator this morning. At this time, I would like to welcome every ...

Danaher (NYSE:DHR) Q3 2026 Earnings call October 21, 2026 08:00 AM ET Company ParticipantsRachel Vatnsdal - VP of Investor RelationsJulie Sawyer Montgomery - President and CEOMatt Gugino - EVP and CFOConference Call ParticipantsDoug Schenkel - AnalystVijay Kumar - AnalystTycho Peterson - AnalystJack Meehan - AnalystScott Davis - AnalystCasey Woodring - AnalystEvie Koslosky - AnalystOperatorMy name is Chelsea, and I will be your conference facilitator this morning. At this time, I would like to welcome every ...

Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Abbott Oct 21, 2026, 07:30 ET ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2026. "Abbott delivered strong third-quarter results, reflecting balanced growth across our portfolio," said Robert B. Ford, chairman and chief executive officer, Abbott. "With strong ...